NVAX
Novavax Inc
Price:  
5.50 
USD
Volume:  
15,124,731.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax Fair Value

-520.07 %
Upside

As of 2024-02-26, the Fair Value of Novavax Inc (NVAX) is -23.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.50 USD, the upside of Novavax Inc is -520.07%.

Note: valuation result may not be accurate due to the company's negative EPS.

5.50 USD
Stock Price
-23.10 USD
Fair Price
FAIR VALUE CALCULATION

Novavax Fair Value

Peter Lynch's formula is:

Novavax Fair Value
= Earnings Growth Rate x TTM EPS
Novavax Fair Value
= 5.00 x -4.62
Novavax Fair Value
= -23.10

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31 5Y Avg
Net income -184.70 -132.70 -418.30 -1,743.80 -657.90 -627.48
YoY growth -0.49% 28.15% -215.22% -316.88% 62.27% -88.43%

Novavax Fair Value - Key Data

Market Cap (mil) 653.35
P/E
Forward P/E
EPS -4.62
Avg earnings growth rate -88.43%
TTM earnings -548.90